E-LIB Suche - Ergebnisse für: Darrow, Jonathan J.

1

Trust in the Food and Drug Administration: A National Surve..:

Feldman, William B. ; Rand, Leah Z. ; Carpenter, Daniel...
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

2

Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anu..:

Rand, Leah Z. ; Carpenter, Daniel P. ; Kesselheim, Aaron S....
Hastings Center Report. 54 (2024) 2 - p. 44-45 , 2024

Link: https://doi.org/10.1002/..

3

CRISPR-phage antibacterials to address the antibiotic resis..:

Pacia, Danielle M ; Brown, Beatrice L ; Minssen, Timo.
Journal of Law and the Biosciences. 11 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

4

Patient perspectives on evidence supporting drug safety and..:

Rand, Leah Z. G. ; McGraw, Sarah ; Wang, Junyi...
Journal of the American Geriatrics Society. , 2024

Link: https://doi.org/10.1111/..

5

Pharmaceutical Innovation in Latin America and the Caribbea:

Vargas, Verónica ; Darrow, Jonathan
Journal of Law, Medicine & Ethics. 51 (2023) S1 - p. 148-162 , 2023

Link: https://doi.org/10.1017/..

6

Variation in Endpoints in FDA Medication Approvals: A Revie..:

Sharpless, Leigh K. ; Kesselheim, Aaron S. ; Orr, Serena L..
Neurology. 101 (2023) 10 - p. , 2023

Link: https://doi.org/10.1212/..

7

Prioritizing Early Disease Intervention:

Caicedo, H. Hugo ; Darrow, Jonathan J. ; Caicedo, Julio C..
Therapeutic Innovation & Regulatory Science. 57 (2023) 6 - p. 1148-1152 , 2023

Link: https://doi.org/10.1007/..

8

An Empirical Review of Key Glucose Monitoring Devices: Prod..:

Darrow, Jonathan J. ; Van de Wiele, Victor ; Beran, David.
Journal of Diabetes Science and Technology. , 2023

Link: https://doi.org/10.1177/..

9

Securing the Trustworthiness of the FDA to Build Public Tru..:

Rand, Leah Z. ; Carpenter, Daniel P. ; Kesselheim, Aaron S....
Hastings Center Report. 53 (2023) S2 - p. , 2023

Link: https://doi.org/10.1002/..

10

Physician Perspectives on the Food and Drug Administration'..:

Dhruva, Sanket S. ; Kesselheim, Aaron S. ; Woloshin, Steven...
Clinical Pharmacology & Therapeutics. 114 (2023) 3 - p. 614-617 , 2023

Link: https://doi.org/10.1002/..

11

Two views of cancer medicines: Imagery versus evidence:

Darrow, Jonathan J.
Health Marketing Quarterly. 40 (2022) 2 - p. 141-152 , 2022

Link: https://doi.org/10.1080/..

12

New Drug Postmarketing Requirements and Commitments in the ..:

Moneer, Osman ; Brown, Beatrice L. ; Avorn, Jerry...
Drug Safety. 45 (2022) 4 - p. 305-318 , 2022

Link: https://doi.org/10.1007/..

13

Recent Orange and Purple Book legislation suggests a need t..:

Walsh, Bryan S. ; Darrow, Jonathan J. ; Kesselheim, Aaron S.
Nature Biotechnology. 40 (2022) 2 - p. 167-169 , 2022

Link: https://doi.org/10.1038/..

14

Experts' Views on FDA Regulatory Standards for Drug and Hig..:

Dhruva, Sanket S. ; Darrow, Jonathan J. ; Kesselheim, Aaron S..
Journal of General Internal Medicine. 37 (2022) 16 - p. 4176-4182 , 2022

Link: https://doi.org/10.1007/..

15

An Orange Book Landscape: Drugs, Patents, and Generic Compe..:

Darrow, Jonathan J. ; Mai, Daniel T. C.
Food and Drug Law Journal. 77 (2022) 1 - p. 51-65 , 2022

Link: https://www.jstor.org/st..